Literature DB >> 1717210

Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.

R Cutait1, V A Alves, L C Lopes, D E Cutait, J L Borges, J Singer, J H da Silva, F S Goffi.   

Abstract

The present study was performed to identify tumor cells in lymph nodes from colorectal adenocarcinomas considered free of disease by the classic hematoxylin-eosin stain, based on the detection of the carcinoembryonic antigen (CEA) and cytokeratins in neoplastic epithelial cells. For this purpose, 603 lymph nodes from 46 lesions were stained by the peroxidase-antiperoxidase technique. Tumor cells were detected in 22 nodes from 12 patients, mainly in the subcapsular sinuses, permitting a restaging of these patients into two groups: those now considered to have metastatic disease and those free of metastases. However, the 5-year follow-up showed no statistical differences in survival between the two groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717210     DOI: 10.1007/bf02049708

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  38 in total

1.  One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases.

Authors:  Thomas F Wood; Dean T Nora; Donald L Morton; Roderick R Turner; Decio Rangel; William Hutchinson; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

Review 2.  Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis.

Authors:  Yong-Ji Zeng; Chun-Dong Zhang; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

Authors:  Zhi-Wei Zhou; Nick Rieger; Andrew Ruszkiewicz; Guo-Qiang Wang; De-Sen Wan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  Detection of micrometastases and skip metastases with ex vivo sentinel node mapping in carcinoma of the colon and rectum.

Authors:  Gokhan Yagci; Aytekin Unlu; Bulent Kurt; Mehmet Fatih Can; Nihat Kaymakcioglu; Sadettin Cetiner; Turgut Tufan; Dervis Sen
Journal:  Int J Colorectal Dis       Date:  2006-05-24       Impact factor: 2.571

Review 5.  Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Authors:  Daniel G Nicastri; John T Doucette; Tony E Godfrey; Steven J Hughes
Journal:  J Mol Diagn       Date:  2007-10-04       Impact factor: 5.568

6.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

7.  Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas.

Authors:  A G Nicholson; C G Marks; M G Cook
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

8.  Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size.

Authors:  Carsten T Viehl; Christian T Hamel; Walter R Marti; Ulrich Guller; Lukas Eisner; Uz Stammberger; Luigi Terracciano; Hans P Spichtin; Felix Harder; Markus Zuber
Journal:  World J Surg       Date:  2003-11-06       Impact factor: 3.352

9.  Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Rodrigo Oliva Perez; Angelita Habr-Gama; Sidney Tomyo Nishida Arazawa; Viviane Rawet; Sheila Aparecida Coelho Siqueira; Desidério Roberto Kiss; Joaquim José Gama-Rodrigues
Journal:  Int J Colorectal Dis       Date:  2005-03-10       Impact factor: 2.571

10.  Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.

Authors:  N P Zauber; C Wang; P S Lee; T C Redondo; D T Bishop; A Goel
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.